LY 201409

RN & structure given in first source

Also Known As:

4-amino-N-(2,6-dimethylphenyl)-3,5-dimethylbenzamide; LY-201409; LY201409

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Ataxia (Dyssynergia) 11/01/1988 - "Studies conducted with the rotorod and horizontal screen assays in mice and behavioral studies in rats suggested that doses of LY201409 that produced CNS side-effects such as sedation or ataxia were well separated from the anti-MES doses. "
2.	Seizures (Absence Seizure) 11/01/1988 - "LY201409 antagonized maximal electroshock (MES)-induced seizures with ED50 values of 16.2 and 4.2 mg/kg after oral administration to mice and rats, respectively. "

1.	Oral Administration